Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Scale Inhibitors Companies

Scale inhibitors companies develop and supply chemicals that prevent the formation of scale in industrial processes. These inhibitors are crucial in industries such as water treatment, oil and gas, and manufacturing, where the accumulation of scale can lead to equipment damage and decreased efficiency.

Scale Inhibitors Key Companies

July 2023


The assignment agreement between CASI Pharmaceuticals Inc. and Cleave Therapeutics Inc. has been executed. As a result, CASI acquired all worldwide intellectual property rights pertaining to CB-5339, a novel VCP/p97 inhibitor, as well as all remaining CB-5339 drug substance and drug product. CASI Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercialising innovative therapeutics and pharmaceutical products. Furthermore, CASI will take over management of the US CB-5339 Investigational New Drug application.


Designed to interfere with protein homeostasis, DNA damage response, and other cellular stress pathways, CB-5339 is an oral, second-generation, small molecule valosin-containing protein/p97 inhibitor. The medication showed signs of clinical activity and was well tolerated in 55 patients in a Phase 1 clinical trial for myelodysplastic syndrome and acute myeloid leukaemia. 


CB-5339 is a novel small molecule drug candidate that holds great promise for targeting VCP/p97 specifically in a range of cancers.


October 2023


With the release of its EVERAD Rapid Inhibitor Test Strip, Wiseman is assisting heating engineers in determining the system's EVERAD Corrosion inhibitor level. By comparing the results with the provided scientific colour map, they can be sure the inhibitor is present at the proper level to protect the system.


Customers can also download its EVERAD Rapid Inhibitor Test app from Google Play or the Apple Store. After using the app, test strip results can be recorded and an emailable Pass/Fail test certificate is generated instantaneously.


Heating engineers are obligated by Building Regulations Part L BS7593 to 'offer' water treatment additives to customers for their heating systems. This is done to make sure the systems are producing the most heat possible. 


Some of the key players operating in the market are 



  • Kemira Oyj of Finland,

  • DowDuPont of the United States,

  • BASF SE of Germany,

  • Solenis of the United States,

  • American Water Chemicals Inc. of the United States,

  • Ecolab of the United States,

  • SUEZ of France,

  • Clariant of Switzerland,

  • BWA Water Additives of the United States and

  • Arkema SA of France.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.